Guidelines for Evaluating an Essential Drugs Programme: PROCEDURES FOR EVALUATION OF AN ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)

Guidelines for Evaluating an Essential Drugs Programme
(64 pages)

Table des matières

INTRODUCTION
PROCEDURES FOR EVALUATION OF AN ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
EXECUTIVE SUMMARY: OVERALL CONCLUSIONS AND RECOMMENDATIONS
1. SUMMARY BACKGROUND INFORMATION ON COUNTRY AND HEALTH CARE SYSTEM¹
2. BRIEF DESCRIPTION OF THE GENERAL FEATURES OF THE APED PROGRAMME
3. ECONOMIC AND SOCIOECONOMIC ASPECTS OF THE APED PROGRAMME
4. ANALYSIS OF EFFICIENCY
	4.1 SELECTION
		4.1.1 SELECTION OF DRUGS
		4.1.2 SELECTION OF ESSENTIAL EQUIPMENT AND DRESSINGS
	4.2 LOGISTICS
		4.2.1 PROCUREMENT
			A. PROCUREMENT METHOD
			B. CONTRACT TERMS
			C. LOCATING AND SELECTING SUPPLIERS
			D. PROCURING
			E. MONITORING SUPPLIER PERFORMANCE
			F. QUALITY ASSURANCE
			G. LOCAL PRODUCTION OF PHARMACEUTICALS OR IMPORT
		4.2.2 DISTRIBUTION
			H. RECEIVING AND INSPECTING
			I. STORAGE AND WAREHOUSING
			J. INVENTORY CONTROL
			K. SUPPLY
			L. DELIVERY
		4.2.3 LOGISTIC SUPPORT
			M. MAINTENANCE AND REPAIR
			N. ENVIRONMENTAL MANAGEMENT OF HEALTH FACILITIES
			O. RECORDS AND REPORTING
	4.3 MANPOWER DEVELOPMENT
		4.3.1 FORMAL TRAINING
		4.3.2 SUPERVISION
	4.4 HEALTH EDUCATION AND INFORMATION
	4.5 POLICY AND LEGAL ASPECTS
		4.5.1 POLICY
		4.5.2 LEGAL ASPECTS
5. ASSESSMENT OF EFFECTIVENESS
	5.1 AVAILABILITY OF DRUGS
	5.2 ACCESSIBILITY OF DRUGS
	5.3 PROPER USE OF DRUGS
	5.4 CLIENT SATISFACTION
	5.5 COMMUNITY INVOLVEMENT
	5.6 MEDICAL ASSESSMENT OF EFFECTIVENESS
6. MANAGING THE ESSENTIAL DRUG PROGRAMME
	6.1 PROGRAMME ORGANIZATION AND MANAGEMENT
		6.1.1 INTERNAL ORGANIZATION
		6.1.2 FINANCIAL MANAGEMENT
		6.1.3 DRUG SUPPLY SYSTEM
		6.1.4 HEALTH CARE DELIVERY SYSTEM
	6.2 BUDGETING, FINANCING AND COSTING
		6.2.1 PATTERNS OF HEALTH EXPENDITURE
		6.2.2 MANAGEMENT AND OPERATIONAL ASPECTS
		6.2.3 ASSESSING COSTS
	6.3 MONITORING
		6.3.1 INDICATORS
		6.3.2 PROCESSING AND ANALYSIS OF DATA
		6.3.3 PRESENTATION AND USE OF MONITORING RESULTS
7. ASSESSMENT OF INPUTS OF THE GOVERNMENT AND DONORS
	7.1 GOVERNMENT
	7.2 WORLD HEALTH ORGANIZATION
	7.3 DONOR(S)
	7.4 OTHER PARTICIPATING AGENCIES
8. PLANNING FOR THE FUTURE
	8.1 PROGRAMME PLANNING
	8.2 PROGRAMME OBJECTIVES
	8.3 PROGRAMME STRATEGY
	8.4 MANAGEMENT
	8.5 FEASIBILITY
	8.6 EXTERNAL ASSISTANCE
9. REFERENCES
MANUAL FOR CONDUCTING AN EVALUATION OF AIM ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
	I. PHASES AND STEPS OF AN APED EVALUATION
		A. INITIATION PHASE
		B. DESIGN PHASE
		C. ADMINISTRATIVE PREPARATION PHASE
		D. FIELD WORK PHASE
		E. ANALYSIS PHASE
		F. DOCUMENTATION PHASE
	II. TIMING
	ANNEX 1 SUGGESTED BUDGET FRAMEWORK
	ANNEX 2 TIMETABLE OF ACTIVITIES DURING THE EVALUATION

PROCEDURES FOR EVALUATION OF AN ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)

Note: These procedures are in accordance with the method and glossary used in the "Health for All" series:

	- no. 4 - Development of Indicators for Monitoring Progress towards Health for All by the Year 2000	(1)
	- no. 5 - Managerial Process for National Health Development	(2)
	- no. 6 - Health Programme Evaluation; and	(3)
	- no. 9 - the Glossary of Terms used in the "Health for All" Series, nos. 1-8	(4)

The number in brackets above and in the PROCEDURES refers to the references in section 9.